إعلان
إعلان

TARA

TARA logo

Protara Therapeutics, Inc. Common Stock

5.69
USD
برعاية
+0.57
+11.13%
٠٧ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

5.72

+0.03
+0.62%

تقارير أرباح TARA

النسبة الإيجابية المفاجئة

TARA تفوق 27 من 40 آخر التقديرات.

68%

التقرير التالي

بيانات التقرير القادم
٠٣ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.35
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
+12.90%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
-28.57%

Protara Therapeutics, Inc. Common Stock earnings per share and revenue

On ١٠ نوفمبر ٢٠٢٥, TARA reported earnings of -0.31 USD per share (EPS) for Q3 25, beating the estimate of -0.39 USD, resulting in a 20.86% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +5.59% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 المحللين forecast an EPS of -0.35 USD, with revenue projected to reach -- USD, implying an زيادة of 12.90% EPS, and زيادة of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
٢٦ ديسمبر ٢٠٢٥ إلى ربع سنوي4 25
تقدير
-$0.49
الفعلي
-
مفاجئة
-
الأسئلة الشائعة
For Q3 2025, Protara Therapeutics, Inc. Common Stock reported EPS of -$0.31, beating estimates by 20.86%, and revenue of $0.00, 0% as expectations.
The stock price moved up 5.59%, changed from $4.29 before the earnings release to $4.53 the day after.
The next earning report is scheduled for ٠٣ مارس ٢٠٢٦.
Based on 7 المحللين, Protara Therapeutics, Inc. Common Stock is expected to report EPS of -$0.35 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان